Embark SPAC Presentation Deck

Expected Use of Proceeds "1 NORTHERN GENESIS II Headcount On-Road Testing OEM Co-Development Expanding Coverage Map Source: Embark / Northern Genesis II Management 70% 13% 12% 5% Proceeds From the Proposed Transaction Are Expected to Fund the Business Plan Through Commercialization in 2024 PRESID 152625 MC#000056 US DOT #2952363 CA#497651 45

View entire presentation